Western Pacific Region Index Medicus

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.

Author: Rui XIONG ¹ ; Leike ZHANG ² ; Shiliang LI ¹ ; Yuan SUN ² ; Minyi DING ¹ ; Yong WANG ³ ; Yongliang ZHAO ³ ; Yan WU ² ; Weijuan SHANG ² ; Xiaming JIANG ² ; Jiwei SHAN ¹ ; Zihao SHEN ¹ ; Yi TONG ¹ ; Liuxin XU ¹ ; Yu CHEN ³ ; Yingle LIU ³ ; Gang ZOU ⁴ ; Dimitri LAVILLETTE ⁴ ; Zhenjiang ZHAO ¹ ; Rui WANG ¹ ; Lili ZHU ¹ ; Gengfu XIAO ² ; Ke LAN ³ ; Honglin LI ⁵ ; Ke XU ⁶
Author Information

1. Shanghai Key Laboratory of New Drug Design, State Key Laboratory of Bioreactor Engineering, School of Pharmacy, East China University of Science and Technology, Shanghai, 200237, China.
2. State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China.
3. State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, 430072, China.
4. CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China.
5. Shanghai Key Laboratory of New Drug Design, State Key Laboratory of Bioreactor Engineering, School of Pharmacy, East China University of Science and Technology, Shanghai, 200237, China. hlli@ecust.edu.cn.
6. State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, 430072, China. xuke03@whu.edu.cn.
Publication Type:Published Erratum
From: Protein & Cell 2022;13(10):778-778
CountryChina
Language:English